| NCT Number | NCT07283718 |
| Lead Sponsor | Wenjin Yin |
| Conditions | Breast Cancer Invasive |
| Enrollment | 2,467 participants |
| Start Date | 2025-09-28 |
| Primary Completion | 2025-10-11 (estimated) |
| Study Completion | 2026-09-28 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-13 |